Compare Stocks → Don’t expose yourself to stocks during the week (From DTI) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:FTTNYSEAMERICAN:HEB No chart dataCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFTTFederated Enhanced Treasury Income Fund$0.00$12.81▼$13.82N/AN/A24,050 shsN/AHEBHemispherx BioPharma$0.48$0.00$1.69▼$14.81$1.17MN/A102,599 shs176,741 shsThese 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free ReportThis company has increased its dividend every year for 54 years (Ad)There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.Click here to get them (for Free).MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFTTFederated Enhanced Treasury Income FundN/AN/AN/AN/AN/AN/AN/AN/AHEBHemispherx BioPharmaN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFTTFederated Enhanced Treasury Income Fund3.00Buy$50.00∞ UpsideHEBHemispherx BioPharmaN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFTTFederated Enhanced Treasury Income FundN/AN/AN/AN/AN/AN/AHEBHemispherx BioPharmaN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFTTFederated Enhanced Treasury Income FundN/AN/A0.00N/AN/AN/AN/AN/AN/AHEBHemispherx BioPharmaN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFTTFederated Enhanced Treasury Income FundN/AN/AN/AN/AN/AHEBHemispherx BioPharmaN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipFTTFederated Enhanced Treasury Income FundN/AHEBHemispherx BioPharmaN/AInsider OwnershipCompanyInsider OwnershipFTTFederated Enhanced Treasury Income FundN/AHEBHemispherx BioPharmaN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableFTTFederated Enhanced Treasury Income FundN/AN/AN/ANot OptionableHEBHemispherx BioPharma312.44 millionN/ANot OptionableHEB, FIJ, FTT, and RAC HeadlinesSourceHeadlineHemispherx BioPharma (NYSEAMERICAN:HEB) Shares Cross Above 200 Day Moving Average of $0.00americanbankingnews.com - April 17 at 2:58 AMH-E-B to donate sauces to every Meals on Wheels of Odessa clientoaoa.com - January 17 at 7:53 PMH-E-B hosting hiring fairscbsnews.com - January 7 at 7:06 PMH-E-B bets on loyal customers as it expands affordable Joe V’s storeschron.com - October 3 at 6:01 PMRoad rage incident leads to stabbing at H-E-Bkens5.com - September 27 at 8:45 AMH-E-B announces new stores in Prosper, Melissa, Rockwallnbcdfw.com - September 25 at 7:28 PMHow H-E-B rewrote the retail playbooktherealdeal.com - September 10 at 2:56 PMH-E-B enters the film world with a five-part docuseries covering Texas parks and wildlifechron.com - August 28 at 6:36 PMNovel Drugs Targeting Toll-like Receptors for Antiviral Therapymedscape.com - July 23 at 12:58 PMFormer H-E-B to become Tesla showroom, filings showstatesman.com - July 20 at 12:34 AMHere's what happened to H-E-B's video rental store you forgot aboutmysanantonio.com - July 10 at 7:43 PMH-E-B opens doors to new Georgetown grocery storebizjournals.com - July 1 at 1:09 PMH-E-B should bring commercials back for No. 1 NBA Draft pick Wembanyamamysanantonio.com - June 29 at 8:53 PMHemispherx's Ampligen Dealt FDA Blowthestreet.com - June 27 at 11:56 PMH-E-B celebrates Corpus Christi educators with the 2023 H-E-B Excellence in Education awardskristv.com - May 4 at 11:43 PMWhat is Mi Tienda? We took a tour of H-E-B's Mexican grocery storehoustonchronicle.com - April 28 at 9:39 AMH-E-B opens first Fresh Bites convenience store in Central Texasmysanantonio.com - April 25 at 8:06 PMH-E-B heir back on Forbes billionaires list, Elon Musk falls from topmysanantonio.com - April 15 at 7:42 PMH-E-B crowned ultimate Texas brand in online competitionbeaumontenterprise.com - April 3 at 9:32 AMB&H Photo promo code for March 2023pcgamer.com - March 30 at 2:50 PMYS Biopharma Down 38%; Reports Favorable Covid-19 Vaccine Resultsmarketwatch.com - March 29 at 7:53 PMHere are five H-E-B products Texans love, as recommended by readershoustonchronicle.com - March 22 at 1:48 AMFirst Wave BioPharma Shares Rise 9% After Dosing First Patient With Adrulipasemarketwatch.com - March 11 at 11:52 PMH-E-B is hiring hundreds of workers for its newest North Texas grocery storestar-telegram.com - February 26 at 3:11 PMMedia Sentiment Over TimeCompany DescriptionsFederated Enhanced Treasury Income FundNYSE:FTTFederated Premier Intermediate Municipal Income Fund (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income tax, including the federal alternative minimum tax (AMT). The Fund's portfolio of investments include various sectors namely transportation, special tax, hospital, education, public power, senior care, water and sewer, general obligation-local, industrial development bond/pollution control revenue and general obligation-state. The Fund invests in intermediate-term, tax-exempt municipal bonds diversified among states, sectors and issuers. Federated Investment Management Company is the advisor of the Fund.Hemispherx BioPharmaNYSEAMERICAN:HEBHemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of CFS, Hepatitis B, HIV, and cancer patients with renal cell carcinoma and malignant melanoma. The company was founded in 1990 and is headquartered in Orlando, Florida. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.